CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Astellas Pharma Inc. v. Windlas Healthcare Pvt. Ltd.

1:16-cv-00930

Overview

Case Number 1:16-cv-00930
Filing Date 2016-10-12
Status Terminated
Termination Date 2020-05-07
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Windlas Biotech Ltd. Operating Company

Represented By

2 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Christine Dealy Haynes

Richards, Layton & Finger

Tel: +1 (302) 651-7508

Richards, Layton & Finger, 920 North King Street

Windlas Healthcare Pvt. Ltd. Operating Company

Represented By

5 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

R. Parrish Freeman

Email: pfreeman@mabr.com

Charles J. Veverka

Email: cveverka@mabr.com

Kent M. Walker

Email: kwalker@brinksgilson.com

Christine Dealy Haynes

Richards, Layton & Finger

Tel: +1 (302) 651-7508

Richards, Layton & Finger, 920 North King Street

Plaintiff

Astellas Pharma Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Defendant

Astellas Pharma Global Development Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Astellas Ireland Co., Ltd. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7342117
α-form or β-form crystal of acetanilide derivative
Filed: 2002-10-20
Issued: 2008-03-11
Expired (Term Ended) +371d PTA
Expires: 2023-10-26
US7982049
α-form or β-form crystal of acetanilide derivative
Filed: 2008-01-14
Issued: 2011-07-19
Expired (Term Ended)
Expires: 2026-04-07
US8835474
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
Filed: 2011-05-27
Issued: 2014-09-16
Active (4.5 yrs remaining)
Expires: 2031-05-27
USRE44872
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
Filed: 2003-11-04
Issued: 2014-04-29
Expired (Term Ended) +44d PTA
Expires: 2023-12-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+371 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 1 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Referred to Magistrate
ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: This case shall be immediately referred to Magistrate Judge Christopher ...
Entry #24 • 2017-08-10 Document →
Claim Construction / Markman Filing Pending
SO ORDERED, re (22 in 1:16-cv-00954-SLR, 25 in 1:16-cv-00908-SLR, 25 in 1:16-cv-00905-SLR, 21 in 1:16-cv-00976-SLR, 24 in 1:16-cv-00924-SLR, 26 in 1:16-cv-00942...
Entry #— • 2017-03-16
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to respond to the Complaint and for Plaintiffs to answer, move, or otherwise respond to any counterclaims to January 1...
Entry #15 • 2017-01-05 Document →

Docket Entries

(52 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Windlas Biotech Ltd., Windlas Healthcare Pvt. Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2011721.)- filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc.(Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(aah) (Entered: 10/12/2016)

Entry #1 • 2016-10-12
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 10/12/2016)

Entry #2 • 2016-10-12
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/8/2016. Date of Expiration of Patent: 11/4/2023.Thirty Month Stay Deadline: 12/28/2019. (aah) (Entered: 10/12/2016)

Entry #3 • 2016-10-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117 B2; 7,982,049 B2; 8,835,474 B2; RE44,872 E; (aah) (Entered: 10/12/2016)

Entry #4 • 2016-10-12
1

Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Astellas US Holding Inc., Other Affiliate Astellas B.V. for Astellas Pharma Inc.; Corporate Parent Astellas US Holding Inc. for Astellas Pharma Global Development Inc.; Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc., Astellas Pharma Inc. (aah) (Entered: 10/12/2016)

Entry #5 • 2016-10-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc